| Annual Financials | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | TTM |
Revenue  | 118 | 137 | 150 | 156 | 172 | 179 | 141 | 203 | 270 | 324 | 402 | 471 | 504 |
| Expenses | 104 | 120 | 127 | 130 | 141 | 130 | 109 | 144 | 193 | 228 | 279 | 326 | 345 |
| EBITDA | 15 | 17 | 23 | 26 | 31 | 49 | 31 | 59 | 77 | 96 | 124 | 145 | 158 |
| Operating Profit % | 12 % | 12 % | 14 % | 15 % | 17 % | 26 % | 22 % | 29 % | 28 % | 29 % | 30 % | 31 % | 31 % |
| Depreciation | 6 | 9 | 9 | 10 | 11 | 21 | 19 | 20 | 20 | 27 | 40 | 46 | 47 |
| Interest | 3 | 4 | 3 | 3 | 3 | 8 | 6 | 6 | 7 | 7 | 13 | 12 | 11 |
| Profit Before Tax | 5 | -1 | 11 | 13 | 17 | 20 | 6 | 32 | 49 | 62 | 71 | 94 | 102 |
| Tax | -0 | -1 | 4 | 7 | 6 | 6 | 7 | 8 | 13 | 16 | 16 | 23 | 25 |
| Net Profit | 6 | 0 | 7 | 7 | 12 | 14 | -1 | 24 | 37 | 46 | 55 | 70 | 76 |
| EPS in ₹ | 12.12 | 0.08 | 15.61 | 14.42 | 25.35 | 29.11 | -3.06 | 51.28 | 78.55 | 98.64 | 116.28 | 147.02 | 158.80 |
Dr. Agrawals Eye Hospital
Dr. Agrawals Eye Hospital
5,346.50
+52.50
(0.99%)
Market Cap
2,583.87 Cr
PE Ratio
33.62
Volume
318.00
Day High - Low
5,400.00 - 5,225.00
52W High-Low
6,059.70 - 4,600.00
Key Fundamentals
Market Cap
2,583.87 Cr
EPS
147.02
PE Ratio
33.62
PB Ratio
7.40
Book Value
716.56
EBITDA
145.31
Dividend Yield
0.08 %
Industry
Healthcare Services Sector
Hospitals Return on Equity
26.07
Debt to Equity
1.64
Analyst Rating and Forecast
- By Refinitiv from1 analysts
Actual
Company News
View All News
Dr Agarwal's Eye Hospital sets AGM date
2 days ago
2 days agoDr Agarwal's Eye Hospital Limited has scheduled its 32nd Annual General Meeting for September 9, 2026. The company published the notice in newspapers and on its website.
Dr. Agarwals Eye Hospital Q1 Results: Net Profit Up YoYAug 03, 2026
Dr. Agarwals Eye Hospital reports Q1 revenue of 1.43B rupees vs 1.17B YoY, net profit at 234M rupees vs 173M YoY, while EBITDA margin narrows to 30.39%.
Dr Agarwals Eye Hospital NCLT hearing on Aug 19Jul 20, 2026
Jul 20, 2026Dr Agarwals Eye Hospital Ltd has announced that the National Company Law Tribunal, Chennai Bench, will hear its amalgamation petition with Dr Agarwal's Health Care Limited on August 19, 2026.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
8,797.00 | #1 1,26,487.36 | 58.69 | #1 25,420.10 | 15.58 | #1 2,003 | 38.41 | 50.48 | |
1,007.80 | 98,083.51 | 67.05 | 8,536.10 | 18.82 | 1,442 | 4.87 | 30.46 | |
909.50 | 68,663.44 | 64.17 | 9,178.50 | 16.93 | 1,064 | 2.25 | 40.91 | |
819.70 | 42,470.38 | 197.02 | 4,643.22 | 8.32 | 384 | -68.70 | 49.64 | |
1,441.60 | 38,759.98 | 68.84 | 4,410.27 | 16.94 | 584 | -1.07 | 54.31 | |
1,810.80 | 37,005.65 | 45.73 | 7,996.30 | #1 43.43 | 811 | 5.39 | 32.93 | |
802.20 | 33,692.92 | 172.90 | 3,930.80 | 28.16 | 242 | -56.00 | 48.36 | |
499.80 | 15,842.81 | 85.63 | 2,080.08 | 18.39 | 168 | #1 44.36 | 50.04 | |
1,464.30 | 14,871.31 | 51.57 | 1,746.90 | 11.49 | 282 | 16.17 | 46.99 | |
277.35 | 11,979.60 | #1 40.25 | 1,679.36 | 17.77 | 272 | 35.27 | 44.09 |
Growth Rate
Revenue Growth
17.07 %
Net Income Growth
28.46 %
Cash Flow Change
5.25 %
ROE
-11.63 %
ROCE
-4.42 %
EBITDA Margin (Avg.)
-0.81 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 69 | 79 | 72 | 81 | 100 | 141 | 155 | 314 | 390 | 496 | 613 | 767 |
| Fixed Assets | 27 | 34 | 33 | 36 | 55 | 94 | 96 | 214 | 260 | 316 | 393 | 600 |
| Current Assets | 23 | 24 | 20 | 23 | 30 | 30 | 44 | 50 | 47 | 60 | 56 | 137 |
| Capital Work in Progress | 0 | 1 | 1 | 3 | 0 | 0 | 0 | 27 | 62 | 97 | 128 | 197 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 13 | 14 |
| Other Assets | 43 | 44 | 38 | 42 | 45 | 47 | 60 | 73 | 67 | 83 | 80 | 0 |
| Total Equity & Liabilities | 69 | 79 | 72 | 81 | 100 | 141 | 155 | 314 | 390 | 496 | 613 | 767 |
| Current Liabilities | 31 | 36 | 27 | 37 | 35 | 39 | 49 | 53 | 55 | 81 | 87 | 111 |
| Non Current Liabilities | 15 | 19 | 16 | 9 | 19 | 45 | 52 | 183 | 222 | 258 | 317 | 309 |
| Total Equity | 24 | 23 | 29 | 35 | 46 | 56 | 55 | 78 | 113 | 157 | 210 | 346 |
| Reserve & Surplus | 19 | 19 | 25 | 30 | 41 | 51 | 50 | 74 | 109 | 152 | 205 | 342 |
| Share Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | -1 | 0 | 0 | -1 | 2 | 2 | 15 | 7 | -1 | 6 | -22 |
| Investing Activities | -10 | -17 | -8 | -11 | -25 | -17 | -11 | -46 | -71 | -70 | -133 |
| Operating Activities | 14 | 17 | 20 | 19 | 25 | 39 | 34 | 57 | 70 | 90 | 95 |
| Financing Activities | -5 | -0 | -12 | -8 | 2 | -20 | -8 | -4 | 0 | -14 | 17 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| Promoter | 74.02 % | 73.77 % | 73.60 % | 72.38 % | 72.15 % | 72.00 % | 71.91 % | 71.90 % | 71.90 % | 71.90 % | 71.90 % | 71.90 % | 71.90 % | 71.90 % | 71.90 % | 71.90 % | 71.90 % | 71.90 % | 72.67 % | 72.67 % | 72.67 % | 72.67 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.28 % | 0.00 % | 0.64 % | 0.65 % | 0.83 % | 0.84 % | 1.33 % | 1.50 % | 1.74 % | 1.82 % | 2.20 % | 2.24 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.96 % | 1.03 % | 1.95 % | 2.31 % | 2.36 % | 2.36 % | 2.12 % | 2.05 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 21.77 % | 22.07 % | 22.23 % | 23.32 % | 23.55 % | 23.63 % | 23.24 % | 22.80 % | 22.65 % | 22.66 % | 22.15 % | 21.84 % | 21.74 % | 21.77 % | 20.51 % | 20.44 % | 19.25 % | 18.95 % | 18.17 % | 17.96 % | 17.93 % | 18.01 % |
| Others | 4.21 % | 4.16 % | 4.17 % | 4.30 % | 4.30 % | 4.37 % | 4.86 % | 5.31 % | 5.46 % | 5.45 % | 5.67 % | 6.27 % | 5.72 % | 5.69 % | 5.80 % | 5.79 % | 5.57 % | 5.34 % | 5.06 % | 5.19 % | 5.07 % | 5.03 % |
| No of Share Holders | 2,492 | 2,462 | 2,444 | 2,741 | 2,764 | 2,791 | 2,858 | 3,006 | 3,110 | 3,169 | 3,471 | 3,423 | 3,572 | 3,808 | 4,510 | 15,115 | 41,704 | 35,976 | 30,528 | 25,449 | 24,036 | 22,954 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 1.5 | 1.2 | 1.5 | 0.00 | 0.00 | 3 | 3 | 2.5 | 6 | 0.00 |
| Dividend Yield (%) | 0.25 | 0.33 | 0.79 | 0.00 | 0.00 | 0.33 | 0.1 | 0.06 | 0.13 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 09 Sept 2026 |  Annual General Meeting | NA | 09 Sept 2026 | 5,472.05 | 5,301.60 |
| 02 Sept 2026 |  Dividend | ₹ 4.00 /share | 02 Sept 2026 | 5,121.05 | 5,301.60 |
| 08 Sept 2022 | Dividend | ₹ 3.00 /share | 06 Sept 2022 | 735.10 | 1,077.00 |
| 15 Sept 2023 | Dividend | ₹ 3.00 /share | 14 Sept 2023 | 1,161.90 | 2,383.25 |
| 31 Oct 2023 | Dividend | ₹ 2.50 /share | 31 Oct 2023 | 2,952.15 | 2,777.00 |
| 20 Aug 2024 | Dividend | ₹ 2.50 /share | 19 Aug 2024 | 3,550.75 | 4,050.35 |
| 26 Aug 2024 | Annual General Meeting | NA | 26 Aug 2024 | 4,000.65 | 4,004.90 |
| 29 Oct 2024 |  Quarterly Result Announcement | NA | 29 Oct 2024 | 5,298.15 | 5,216.10 |
| 08 Nov 2024 | Dividend | ₹ 2.50 /share | 08 Nov 2024 | 5,216.10 | 5,229.45 |
| 14 Feb 2025 | Quarterly Result Announcement | NA | 14 Feb 2025 | 4,361.05 | 4,148.75 |
| 28 May 2025 | Quarterly Result Announcement | NA | 28 May 2025 | 4,275.65 | 4,375.65 |
| 12 Aug 2025 | Quarterly Result Announcement | NA | 12 Aug 2025 | 4,393.45 | 4,424.65 |
| 18 Sept 2025 | Dividend | ₹ 3.50 /share | 18 Sept 2025 | 4,375.65 | 4,653.40 |
| 24 Sept 2025 | Annual General Meeting | NA | 24 Sept 2025 | 5,145.65 | 4,746.50 |
| 30 Oct 2025 | Quarterly Result Announcement | NA | 30 Oct 2025 | 5,278.00 | 5,100.45 |
| 07 Nov 2025 | Dividend | ₹ 3.00 /share | 07 Nov 2025 | 5,100.45 | 5,223.95 |
| 03 Feb 2026 | Quarterly Result Announcement | NA | 03 Feb 2026 | 4,674.15 | 4,670.45 |
| 20 May 2026 | Quarterly Result Announcement | NA | 20 May 2026 | 5,100.00 | 5,121.05 |
| 02 Jul 2026 |  Extraordinary General Meeting | NA | 02 Jul 2026 | 4,966.50 | 5,049.00 |
| 03 Aug 2026 | Quarterly Result Announcement | NA | 03 Aug 2026 | 5,041.50 | 5,022.50 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication2 days ago
2 days ago32Nd Annual General Meeting Of The Members Of The Company- September 09 20263 days ago
3 days agoIntimation Of Record Date Under Regulation 42 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 20153 days ago
3 days agoReg. 34 (1) Annual Report.3 days ago
3 days agoDisclosures under Reg. 29(1) of SEBI (SAST) Regulations 20114 days ago
4 days agoAnnouncement under Regulation 30 (LODR)-Change in ManagementAug 03, 2026
Aug 03, 2026Results- Unaudited Financial Results For The Quarter Ended June 30 2026Aug 03, 2026
Aug 03, 2026Board Meeting Outcome for Outcome Of The Board Meeting Held On August 03 2026Aug 03, 2026
Aug 03, 2026Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results For The Quarter Ended June 30 2026Jul 28, 2026
Jul 28, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 20, 2026
Jul 20, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 07, 2026
Jul 07, 2026Voting Results Of The Honble NCLT Convened Meeting Of The Unsecured CreditorsJul 02, 2026
Jul 02, 2026Summary Of The Proceedings Of The Honble NCLT Convened Meeting Of The Unsecured Creditors Of Dr. Agarwals Eye Hospital Limited Held On July 02 2026Jul 02, 2026
Jul 02, 2026Voting Results Of The Honble NCLT Convened Meeting Of The Secured CreditorsJul 02, 2026
Jul 02, 2026Summary Of The Proceedings Of The Honble NCLT Convened Meeting Of The Secured Creditors Of Dr. Agarwals Eye Hospital Limited Held On July 02 2026Jul 02, 2026
Jul 02, 2026Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJul 02, 2026
Jul 02, 2026Shareholder Meeting / Postal Ballot-Outcome of Court Convened MeetingJul 02, 2026
Jul 02, 2026Closure of Trading WindowJun 20, 2026
Jun 20, 2026Announcement under Regulation 30 (LODR)-Credit RatingJun 16, 2026
Jun 16, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 01, 2026
Jun 01, 2026Letter To Equity Shareholders And CreditorsJun 01, 2026
Jun 01, 2026Announcement under Regulation 30 (LODR)-Scheme of ArrangementJun 01, 2026
Jun 01, 2026Announcement under Regulation 30 (LODR)-Scheme of ArrangementJun 01, 2026
Jun 01, 2026Notice Convening Meeting Of The Equity Shareholders Of The Company Pursuant To The Order Of Honble NCLT Chennai BenchJun 01, 2026
Jun 01, 2026Corporate Action-Board approves DividendMay 20, 2026
May 20, 2026Board Meeting Outcome for Consideration And Approval Of Audited Financial Results For The Quarter And Year Ended March 31 2026 And Declaration Of Final Dividend For The Financial Year Ended March 31 2026May 20, 2026
May 20, 2026Audited Financial Results Of The Company For The Quarter And Year Ended March 31 2026May 20, 2026
May 20, 2026Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results Of The Company For The Quarter And Year Ended March 31 2026May 14, 2026
May 14, 2026Receipt Of Order Passed By The HonBle NCLT In Relation To The Scheme Of Amalgamation Between Dr. AgarwalS Eye Hospital Limited And Dr. AgarwalS Health Care LimitedMay 11, 2026
May 11, 2026Trading And Admission To Dealings Of The CompanyS Equity Shares On The National Stock Exchange Of India LimitedApr 21, 2026
Apr 21, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 07, 2026
Apr 07, 2026Closure of Trading WindowMar 24, 2026
Mar 24, 2026Announcement under Regulation 30 (LODR)-Credit RatingFeb 23, 2026
Feb 23, 2026Announcement under Regulation 30 (LODR)-Scheme of ArrangementFeb 17, 2026
Feb 17, 2026Announcement under Regulation 30 (LODR)-Change in Registered Office AddressFeb 03, 2026
Feb 03, 2026Results- Financial Results For The Quarter And Nine Months Ended December 31 2025Feb 03, 2026
Feb 03, 2026Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025Feb 03, 2026
Feb 03, 2026Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025Jan 28, 2026
Jan 28, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 12, 2026
Jan 12, 2026Closure of Trading WindowDec 26, 2025
Dec 26, 2025Corporate Action-Board approves DividendOct 30, 2025
Oct 30, 2025Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025Oct 30, 2025
Oct 30, 2025Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025 And Declaration Of Interim DividendOct 30, 2025
Oct 30, 2025Corporate Action - Fixes Record Date As November 07 2025 For The Purpose Of Interim Dividend If Declared By The BoardOct 27, 2025
Oct 27, 2025Update on board meetingOct 27, 2025
Oct 27, 2025Board Meeting Intimation for Considering And Approving The Un-Audited Financial Results For The Quarter And Half-Year Ended September 30 2025Oct 22, 2025
Oct 22, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 07, 2025
Oct 07, 2025Closure of Trading WindowSep 26, 2025
Sep 26, 2025Announcement under Regulation 30 (LODR)-AllotmentSep 26, 2025
Sep 26, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 25, 2025
Sep 25, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.04% | 0 | 0.00% | 0.00% | |
 PGIM India Healthcare Fund Direct-Growth | 0.45% | 0 | 0.00% | -0.04% | |
PGIM India Retirement Fund Direct-Growth | 0.21% | 0 | 0.00% | -0.01% | |
 WhiteOak Capital Pharma and Healthcare Fund Direct-Growth | 0.00% | 0 | 0.00% | 0.00% |
Technical Indicators
RSI(14)
Neutral 60.09
ATR(14)
Volatile 174.55
STOCH(9,6)
Neutral 59.65
STOCH RSI(14)
Neutral 67.77
MACD(12,26)
Bullish 21.99
ADX(14)
Strong Trend 41.03
UO(9)
Bearish 48.17
ROC(12)
Uptrend And Accelerating 6.00
WillR(14)
Neutral -49.00
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
